Financhill
Back

Moderna 10K Form

Sell
40

MRNA
Moderna

Last Price:
147.67
Seasonality Move:
21.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRNA News And Ratings

See the #1 stock for the next 7 days that we like better than MRNA

MRNA Financial Statistics

Sales & Book Value

Annual Sales: $6.75B
Cash Flow: $-1.19B
Price / Cash Flow: 0
Annual Sales: $33.46
Price / Book: 4.44

Profitability

EPS (TTM): -15.67000
Net Income (TTM): $-5.97B
Gross Margin: $2.06B
Return on Equity: -39.3%
Return on Assets: -29.66%

Moderna Earnings Forecast

Key Moderna Financial Ratios

  • The Gross Profit Margin over the past 6 years for MRNA is 30.52%.
  • The Selling, General & Administrative Expenses for MRNA have been equal to 22.93% of Gross Profit Margin.
  • The Research & Development expenses have been 71.74% of Revenue.
  • The Interest Expense is -0.81% of Operating Income.
  • The Net Earning history of MRNA is -69.80% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Moderna Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MRNA
CUSIP: 60770K
Website: modernatx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.03
Quick Ratio: 3.74

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRNA Technical Analysis vs Fundamental Analysis

Sell
40
Moderna (MRNA) is a Sell

Is Moderna a Buy or a Sell?

  • Moderna stock is rated a Sell
    The current Moderna [MRNA] share price is $148.39. The Score for MRNA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.